| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 28007-87-6 | Guanosine,7,8-dihydro-7-methyl-8-oxo-; Purine-6,8(1H,9H)-dione,2-amino-7-methyl-9-b-D-ribofuranosyl- (8CI); 7-Methyl-8-oxoguanosine; NSC 127522 |  | C11H15N5O6 | 詳情 | 供應商 | |
| 3887-13-6 | Glycine,glycylglycylglycylglycylglycyl-; Glycine,N-[N-[N-[N-(N-glycylglycyl)glycyl]glycyl]glycyl]- (6CI,8CI); (Glycine)6; 112:PN: US20080213898 SEQID: 101 unclaimed sequence; 12: PN: US20030086940 SEQID:12 claimed sequence; 136: PN: JP2005002106 SEQID: 84 unclaimed sequence; 177:PN: WO2009150215 SEQID: 196 claimed sequence; 20: PN: WO2008157824 SEQID: 143unclaimed sequence; 251: PN: US20090029924 SEQID: 227 unclaimed sequence; 25:PN: WO2007015107 SEQID: 29 claimed protein; 27: PN: US20080020405 PAGE: 19unclaimed sequence; 2: PN: WO03094849 SEQID: 3 unclaimed sequence; 30: PN:WO2008094316 PAGE: 66 claimed sequence; 33: PN: WO2004042059 SEQID: 44 unclaimedsequence; 42: PN: WO03087129 SEQID: 43 unclaimed sequence; 4: PN: US20060057559SEQID: 3 unclaimed sequence; 59: PN: US20080095758 SEQID: 57 claimed sequence; 6: PN: CN101165070 SEQID: 7 claimed protein; 9: PN: CN101260157 SEQID: 9claimed sequence; Gly6; Glycylglycylglycylglycylglycylglycine; H-Gly-Gly-Gly-Gly-Gly-Gly-OH; Hexaglycine; NSC 402061 |  | C12H20N6O7 | 詳情 | 供應商 | |
| 54237-72-8 | Guanidine,N-cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]sulfinyl]ethyl]-; Guanidine,N-cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfinyl]ethyl]-(9CI); (?à)-Cimetidine S-oxide; Cimetidinesulfoxide; SKF 92452 |  | C10H16N6OS | 詳情 | 供應商 | |
| 137608-89-0 | Guanosine,2'-deoxy-4,8-dihydro-4-hydroxy-8-oxo-, (4R)- (9CI); 4,8-dihydro-4-hydroxy-8-oxo-2'-deoxyguanosine |  | C10H13N5O6 | 詳情 | 供應商 | |
| 2371-32-6 | Glycine,N-(m-bromophenyl)-, hydrazide (7CI,8CI); NSC 190336 |  | C8H10BrN3O | 詳情 | 供應商 | |
| 117383-28-5 | Glycine, N-[N-L-g-glutamyl-S-(2,4,5-trichloro-3,6-dioxo-1,4-cyclohexadien-1-yl)-L-cysteinyl]-(9CI); 2,5,6-Trichloro-3-(glutathion-S-yl)-1,4-benzoquinone |  | C16H16Cl3N3O8S | 詳情 | 供應商 | |
| 10463-61-3 | Glycine, L-g-glutamyl-S-(carboxymethyl)-L-cysteinyl-; Glutamine,N-[1-[(carboxymethyl)carbamoyl]-2-[(carboxymethyl)thio]ethyl]-, L- (8CI); Glycine, N-[[S-(carboxymethyl)-N-L-g-glutamyl]-L-cysteinyl]-; 2-(S-Glutathionyl)acetic acid; S-(Carboxymethyl)glutathione |  | C12H19N3O8S | 詳情 | 供應商 | |
| 75511-49-8 | Guanidine,N'-cyano-N,N''-dimethyl-N-nitroso-; 1,3-Dimethyl-2-cyano-1-nitrosoguanidine; 2-Cyano-1,3-dimethyl-1-nitrosoguanidine |  | C4H7N5O | 詳情 | 供應商 | |
| 103345-93-3 | Glucagon-like peptide I(Lophius americanus) (9CI); Glucagon-relatedpeptide I (Lophius americanus); Glucagon-related peptide (Oncorhynchuskisutch), 6-L-phenylalanine-9-L-asparticacid-12-L-serine-15-L-lysine-19-L-isoleucine-24-L-asparticacid-25-L-arginine-28-L-alanine-30-L-glutamine-31-L-valine-; L-Valine,L-histidyl-L-alanyl-L-a-aspartylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-a-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-lysyl-L-a-aspartyl-L-glutaminyl-L-alanyl-L-isoleucyl-L-lysyl-L-a-aspartyl-L-phenylalanyl-L-valyl-L-a-aspartyl-L-arginyl-L-leucyl-L-lysyl-L-alanylglycyl-L-glutaminyl- |  | C150H235N41O50 | 詳情 | 供應商 | |
| 6948-99-8 | Guanidine,N-(5,8-dihydro-1-naphthalenyl)-, hydrochloride (1:1); Guanidine,(5,8-dihydro-1-naphthalenyl)-, monohydrochloride (9CI); NSC 20603 |  | C11H14ClN3 | 詳情 | 供應商 | |
| 133872-49-8 | Glycine, L-g-glutamyl-S-[1-(hydroxymethyl)-2-propenyl]-L-cysteinyl-(9CI); Glycine,N-[N-L-g-glutamyl-S-[1-(hydroxymethyl)-2-propenyl]-L-cysteinyl]- |  | C14H23N3O7S | 詳情 | 供應商 | |
| 17092-47-6 | Glycine,N-[(1-piperidinyloxy)carbonyl]-; Glycine,N-[(piperidinooxy)carbonyl]- (8CI); Piperidine,1-[[(carboxymethyl)carbamoyl]oxy]-; Piperidine, 1-[[[(carboxymethyl)amino]carbonyl]oxy]- |  | C8H14N2O4 | 詳情 | 供應商 | |
| 59005-83-3 | Glycine,L-phenylalanylglycyl-L-phenylalanyl-; Glycine,N-[N-(N-L-phenylalanylglycyl)-L-phenylalanyl]-; L-Phe-Gly-L-Phe-Gly; NSC 343027 |  | C22H26N4O5 | 詳情 | 供應商 | |
| 5132-79-6 | Guanosine,2'-deoxy-1-methyl-; 1-Methyl-2'-deoxyguanosine; N1-Methyl-2'-deoxyguanosine; NSC 70899 |  | C11H15N5O4 | 詳情 | 供應商 | |
| 29779-51-9 | Glycine,N-methyl-N-[2,3,5,6-tetraiodo-4-(4-morpholinylcarbonyl)benzoyl]-; Hippuricacid, 2,3,5,6-tetraiodo-b-methyl-4-(morpholinocarbonyl)- (8CI) |  | C15H14I4N2O5 | 詳情 | 供應商 | |
| 32266-35-6 | Guanosine,N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate; Butyramide,N-(1,6-dihydro-6-oxo-9-b-D-ribofuranosyl-9H-purin-2-yl)-, cyclic hydrogen phosphate butyrate(ester) (8CI); 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, guanosine deriv.; Butyricacid, monoester with N-(1,6-dihydro-6-oxo-9-b-D-ribofuranosyl-9H-purin-9-yl)butyramide cyclichydrogen phosphate (8CI); Cyclic N2,2'-O-dibutyryl-3',5'-GMP; Cyclic dibutyrylGMP; Dibutyryl 3',5'-cyclic GMP; Dibutyryl cGMP; Dibutyryl cyclic GMP; Dibutyryl cyclic guanosine 3',5'-monophosphate; Dibutyryl cyclic guanosinemonophosphate; Dibutyrylguanosine 3',5'-monophosphate; Dibutyrylguanosinecyclic 3',5'-monophosphate; N2,2'-O-Dibutyryl cyclic 3',5'-GMP; N2,2'-O-Dibutyryl cyclic GMP; N2,2'-O-Dibutyryl-cGMP; N2,2'-O-Dibutyrylguanosine 3',5'-cyclic phosphate; N2,2'-O-Dibutyrylguanosine3',5'-monophosphate; N2,O2'-Dibutyryl cGMP; N2,O2'-Dibutyryl cyclic GMP; N2,O2'-Dibutyrylguanosine3',5'-cyclic monophosphate; N2,O2'-Dibutyrylguanosine cyclic 3',5'-phosphate |  | C18H24N5O9P | 詳情 | 供應商 | |
| 729-20-4 | Guanidine,N-([1,1'-biphenyl]-4-ylmethoxy)-; Guanidine,([1,1'-biphenyl]-4-ylmethoxy)- (9CI); Guanidine, [(p-phenylbenzyl)oxy]-(7CI,8CI); [(p-Phenylbenzyl)oxy]guanidine |  | C14H15N3O | 詳情 | 供應商 | |
| 104821-31-0 | Glycinamide, L-a-aspartyl-L-prolylglycyl-L-phenylalanyl-L-seryl-L-seryl-L-tryptophyl-(9CI); LeukokininI, 3-glycine-5-L-serine-; Leucokinin II; Leukokinin II |  | C39H50N10O12 | 詳情 | 供應商 | |
| 85563-30-0 | Glycine,N-[N-(1-L-tyrosyl-L-prolyl)glycyl]- (9CI); tyrosyl-prolyl-glycyl-glycine |  | C18H24N4O6 | 詳情 | 供應商 | |
| 23555-96-6 | Glycine,N,N-bis(carboxymethyl)-, potassium strontium salt (2:4:1); Aceticacid, nitrilotri-, potassium strontium salt (2:4:1) (8CI) |  | C6H9NO6.2K.1/2Sr | 詳情 | 供應商 | |